Total Payments
$20,034
2024 Payments
$3,712
Companies
44
Transactions
1,015
Medicare Patients
2,840
Medicare Billing
$229,680
Payment Breakdown by Category
Food & Beverage$19,021 (94.9%)
Travel$854.21 (4.3%)
Education$158.60 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,021 | 1,007 | 94.9% |
| Travel and Lodging | $854.21 | 1 | 4.3% |
| Education | $158.60 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,879 | 189 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,771 | 108 | $0 (2024) |
| ABBVIE INC. | $1,642 | 95 | $0 (2024) |
| Amgen Inc. | $1,463 | 72 | $0 (2024) |
| Lilly USA, LLC | $1,341 | 72 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,226 | 75 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $1,214 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,176 | 58 | $0 (2022) |
| GlaxoSmithKline, LLC. | $612.74 | 51 | $0 (2024) |
| PFIZER INC. | $550.63 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,712 | 106 | CALLIDITAS THERAPEUTICS US INC. ($1,214) |
| 2023 | $2,564 | 136 | Novo Nordisk Inc ($477.64) |
| 2022 | $2,507 | 116 | Novo Nordisk Inc ($848.67) |
| 2021 | $2,992 | 154 | Novo Nordisk Inc ($699.06) |
| 2020 | $1,702 | 115 | AstraZeneca Pharmaceuticals LP ($271.75) |
| 2019 | $1,985 | 138 | Novo Nordisk Inc ($661.79) |
| 2018 | $2,475 | 128 | AstraZeneca Pharmaceuticals LP ($605.69) |
| 2017 | $2,096 | 122 | AstraZeneca Pharmaceuticals LP ($336.02) |
All Payment Transactions
1,015 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Obesity | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.17 | General |
| Category: Allergy/Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: Hematology | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: VACCINES | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $854.21 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $360.00 | General |
| Category: Nephrology | ||||||
| 09/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.50 | General |
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 562 | 834 | $187,523 | $52,971 |
| 2022 | 10 | 698 | 1,045 | $204,922 | $61,995 |
| 2021 | 11 | 747 | 1,086 | $206,376 | $64,515 |
| 2020 | 14 | 833 | 1,164 | $182,140 | $50,199 |
Total Patients
2,840
Total Services
4,129
Medicare Billing
$229,680
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 232 | $64,395 | $16,736 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 294 | $57,624 | $15,861 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 81 | 81 | $29,788 | $9,531 | 32.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 50 | $10,510 | $3,690 | 35.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 46 | 46 | $11,275 | $3,229 | 28.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 59 | 61 | $3,475 | $1,779 | 51.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,908 | $1,687 | 18.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 30 | 48 | $1,548 | $456.96 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 292 | $81,176 | $21,411 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 322 | $63,112 | $17,675 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 81 | 81 | $27,297 | $9,908 | 36.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 62 | 62 | $5,208 | $4,285 | 82.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 54 | 54 | $13,500 | $3,077 | 22.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 80 | 82 | $3,034 | $2,303 | 75.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,783 | $1,732 | 25.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 51 | 105 | $3,780 | $999.05 | 26.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 18 | 18 | $900.00 | $564.27 | 62.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 12 | $132.00 | $41.32 | 31.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 177 | 278 | $75,023 | $22,051 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 168 | 360 | $67,159 | $19,788 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 86 | 86 | $28,619 | $10,823 | 37.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 62 | 62 | $15,572 | $4,007 | 25.7% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 11 | 11 | $4,600 | $2,633 | 57.2% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 69 | 73 | $2,908 | $1,472 | 50.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $4,788 | $1,176 | 24.6% |
About Dr. Mohammad Baloch, MD
Dr. Mohammad Baloch, MD is a Family Medicine healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295708592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Baloch, MD has received a total of $20,034 in payments from pharmaceutical and medical device companies, with $3,712 received in 2024. These payments were reported across 1,015 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($19,021).
As a Medicare-enrolled provider, Baloch has provided services to 2,840 Medicare beneficiaries, totaling 4,129 services with total Medicare billing of $229,680. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Raleigh, NC
- Active Since 02/08/2006
- Last Updated 05/06/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1295708592
Products in Payments
- FARXIGA (Drug) $1,915
- Ozempic (Drug) $1,738
- TARPEYO (Drug) $1,214
- JARDIANCE (Drug) $1,032
- UBRELVY (Drug) $810.79
- XARELTO (Drug) $712.64
- MOUNJARO (Drug) $591.25
- VRAYLAR (Drug) $583.24
- Rybelsus (Drug) $488.56
- INVOKANA (Drug) $462.99
- Wegovy (Drug) $441.17
- EVENITY (Biological) $421.07
- Saxenda (Drug) $416.80
- TRULICITY (Drug) $396.78
- Otezla (Drug) $391.12
- JANUVIA (Drug) $383.48
- NURTEC ODT (Drug) $360.64
- Vascepa (Drug) $356.12
- AIRSUPRA (Drug) $294.24
- Repatha (Biological) $282.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Raleigh
William Cromwell, M.d, M.D
Family Medicine — Payments: $1.4M
Family Medicine $1.4M
Dr. Amish Patel, Md, MD
Family Medicine — Payments: $58,222
Family Medicine $58,222
Scott Brundle, Md, MD
Family Medicine — Payments: $29,978
Family Medicine $29,978
John Burkard, M.d, M.D
Family Medicine — Payments: $24,130
Family Medicine $24,130
Kristina Kohuth, Pa-C, PA-C
Family Medicine — Payments: $18,377
Family Medicine $18,377
Anu Bommareddi, M.d, M.D
Family Medicine — Payments: $14,082
Family Medicine $14,082